Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Bone Neoplasms × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Breast Neoplasms 2 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Lymphoma 1 Leiomyoma 1 Hot Flashes 1 Bone Neoplasms 1

Interventions

Vincristine 2 Temozolomide 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Doxorubicin 2 Cyclophosphamide 2 selinexor 1 samarium Sm-153 lexidronam 1 robatumumab 1 pembrolizumab 1 pegfilgrastim 1 angiotensin I (1-7) 1 Zoledronic Acid 1 Transcranial Direct Current Stimulation 1 Tranexamic Acid 1 Sunitinib 1 Standard of Care 1 Sodium Pertechnetate Tc 99m 1 Sodium Chloride 1 Samarium 1 Radiosurgery 1 Radiation 1 Proton Therapy 1 Pregabalin 1 Practice Guidelines as Topic 1 Plicamycin 1 Palliative Care 1 Nivolumab 1 Neutrons 1 Methods 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡